HOST-DIRECTED FDA-APPROVED DRUGS WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 IDENTIFIED BY HIERARCHICAL IN SILICO/IN VITRO SCREENING METHODS Artículo académico